Zeo ScientifiX (ZEOX) Gains from Sales and Divestitures (2023)
Zeo ScientifiX (ZEOX) reported Gains from Sales and Divestitures of $374,000 for fiscal Q4 2023 (quarter ended Oct 31, 2023).
Powered by 
Analysis
Zeo ScientifiX (ZEOX) Gains from Sales and Divestitures (2023) Analysis & Trends
For FY2023 (ended Oct 31, 2023), Zeo ScientifiX posted Gains from Sales and Divestitures of $341,000.
- Gains from Sales and Divestitures has a five-year compound annual growth rate of -16.1% (FY2018 to FY2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Zeo ScientifiX | 9.73 Mn | 6.32 Mn | 2.06 Mn |
API Access
Zeo ScientifiX Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ZEOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "ZEOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ZEOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();